TLDR:
Key Points:
- Kristina Burow is a managing director at ARCH Venture Partners, known for her work in building bold startups like Orbital Therapeutics and Neumora Therapeutics.
- Burow discusses her passion for impacting patients, her involvement in the neuroscience field, and her ideas for changing the dynamics between drug companies and government.
Kristina Burow, a managing director at ARCH Venture Partners, is recognized for her influence in building startups like Orbital Therapeutics and Neumora Therapeutics in the biotech industry. Burow’s journey began as a chemistry major at UC Berkeley and eventually led her to work closely with esteemed individuals in the field of organic chemistry. Burow’s experience at ARCH is centered around asking fundamental questions to bring about change in therapeutic areas. She emphasizes the need for more diverse approaches in the industry and advocates for incentives to encourage innovation.
Burow’s involvement in the neuroscience field with Neumora Therapeutics reflects her frustration with the lack of options for individuals with mental illness. While progress has been made, Burow believes there is still room for improvement in bringing new treatments to market. She envisions opportunities in precision immunology and a focus on understanding the biological differences between men and women in drug development. Burow’s insights shed light on her dedication to making impactful investments in the biotech industry.
